GGR Q1 2026 Earnings EPS Reports 048 as Gogoro Navigates Challenges LNKB Q4 2025 Earnings EPS Misses Estimates Amid Challenging Rate Environment RVMD Q1 2026 Earnings EPS Miss Signals Higher RD Spending Amid LateStage Pipeline Push CSAI Q4 2025 Earnings Loss Widens Amid Transition Stock Falls 24 Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady Cato Q4 2025 Earnings Loss Widens as Retail Headwinds Persist